Assyro AI

FDA Orange Book · active-ingredient family

Ferric hexacyanoferrate(ii)

Ferric hexacyanoferrate(ii) is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

1

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
RADIOGARDASE (PRUSSIAN BLUE)RLDHEYL CHEMISCHNDA 021626Oct 02, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ferric hexacyanoferrate(ii) — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.